Research, Publications and Grants

The Alzheimer's Association offers a wide range of peer-reviewed journals, research data platforms and grant programs designed to support researchers at every stage of their work. Whether you’re applying for funding, exploring research resources or managing grant opportunities, you’ll find valuable tools and support here to advance your studies.

Peer-Reviewed Journals

Stay informed with publications that highlight breakthroughs in Alzheimer’s research, care practices and the broader science of aging and dementia. These journals bring together leading researchers and clinicians to share evidence, explore innovations and shape the future of dementia science.

See All Journals

Publications, Guidelines and Other Evidence

Access Alzheimer’s Association guidelines and recommendations grounded in the latest scientific evidence. These resources help ensure consistent, high-quality dementia care through standardized practices, expert consensus and real-world data.

See All Publications, Guidelines and Other Evidence

Dementia Care Navigation Guiding Principles

A summary of best practices for delivering person-centered dementia care navigation across clinical and community-based settings.

Discussing Anti-Amyloid Treatments with Patients

Tips and communication strategies to help clinicians have informed, person-centered conversations about anti-amyloid therapies.

Lecanemab Resources for Health Care Professionals

Lecanemab (Leqembi™) is an FDA-approved intravenous monoclonal antibody therapy indicated for the treatment of early Alzheimer’s disease (AD).

Appropriate Use Criteria: Lumbar Puncture and Cerebrospinal Fluid Testing

Expert guidance on when and how to use cerebrospinal fluid testing to support an accurate Alzheimer’s disease diagnosis.

Appropriate Use Criteria for Amyloid and Tau PET Imaging

Updated guidance for clinicians on using amyloid and tau PET imaging to support Alzheimer’s disease evaluation and diagnosis.

Criteria for Staging and Diagnosis (FKA NIA-AA Criteria)

Consensus-based clinical and biological staging framework for Alzheimer’s disease to support early, accurate diagnosis.

Systematic Review: Blood-Based Biomarkers For Detecting Alzheimer's Disease Pathology In Cognitively Impaired Individuals Within Specialized Care Settings

Systematic review evaluating the accuracy of blood-based biomarkers.

Donanemab Resources for Health Care Professionals

Guidance and planning resources to help providers evaluate, prepare for and manage treatment with Donanemab in clinical practice.

Alzheimer’s Disease Facts and Figures

An annual report offering the latest data on Alzheimer’s prevalence, cost, caregiving impact and public health implications in the U.S.

Pre-analytical Standardization for Alzheimer's Blood Biomarkers

Evidence-based research defining how sample handling variables affect blood-based Alzheimer’s biomarker accuracy and providing a standardized protocol.

Clinical Practice Guidelines Overview

Standardized clinical recommendations are rolling out in late summer 2025 – bookmark for the latest updates.

Clinical Practice Guideline: Blood-Based Biomarkers in Specialty Care

An evidence-informed guideline and tools focused on the use of blood tests for diagnosis in specialty care settings.

Diagnostic Evaluation, Testing, Counseling and Disclosure of Suspected Alzheimer's Disease

DETeCD-ADRD offers a five-step approach to support early diagnosis, accurate evaluation and compassionate disclosure in clinical care.

Dementia Care Practice Recommendations

Evidence-informed guidelines to define and promote quality, person-centered care for individuals living with dementia in long-term and community-based care settings.

International Research Grant Program (IRGP)

Funding innovative studies to advance Alzheimer’s research, improve care and explore strategies for brain health and disease prevention.

Part the Cloud

Funds early-phase clinical trials to accelerate the development of Alzheimer’s treatments and move promising ideas from lab to clinic.

Center for Dementia Respite Innovation

Funds and supports respite care programs that serve dementia caregivers, with a focus on expanding access in underserved communities.

Research Studies and Recruitment Tools

Connect to tools that support research study participation, recruitment and design in Alzheimer's and dementia research. These resources help researchers, care providers and individuals work together to advance discovery and accelerate access to treatments.

See All Clinical Trial Resources